Vaginal cancer
MONDO:0001402A primary or metastatic malignant neoplasm involving the vagina. Representative examples include carcinomas and sarcomas.
Also known as: vagina neoplasm, vaginal tumor, vaginal tumour, cancer of vagina, malignant neoplasm of the vagina, malignant neoplasm of vagina, malignant tumor of the vagina, malignant tumor of vagina
2885 clinical trials for this condition and its sub-types, 53 tagged with Vaginal cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Vaginal cancer
-
Vaginal carcinoma 12 trials · 22 incl. sub-types
2 sub-types
- Vaginal squamous cell carcinoma 8 trials
- Vaginal adenocarcinoma 7 trials Sub-types →
-
1 sub-type
- Vaginal carcinosarcoma 0 trials
-
Vagina sarcoma 0 trials
3 sub-types
- Endometrioid stromal sarcoma of the vagina 0 trials
- Vagina leiomyosarcoma 0 trials
- Vaginal rhabdomyosarcoma 0 trials Sub-types →
-
Vaginal adenosarcoma 0 trials
-
Vaginal germ cell malignant tumor 0 trials
1 sub-type
- Vaginal yolk sac tumor 0 trials
Most studied deeper sub-types
-
New HPV vaccine combo aims to fight Hard-to-Treat cancers
Disease control CompletedThis study tests an HPV vaccine (PRGN-2009) alone or with a drug called M7824 in people with HPV-positive cancers like cervical, anal, and throat cancers. The goal is to find a safe dose and see if the combination boosts the immune system's attack on tumors. The trial includes 39…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Triple immunotherapy attack shows promise against Hard-to-Treat HPV cancers
Disease control CompletedThis study tests a combination of three immunotherapy drugs—PDS0101, M7824, and NHS-IL12—in people with advanced HPV-related cancers such as cervical, anal, and throat cancers. The goal is to see if the mix can shrink tumors or stop them from growing. Participants receive the dru…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Engineered immune cells take on HPV cancers
Disease control CompletedThis trial tested a new therapy for cancers caused by HPV-16, such as cervical, anal, and throat cancers. Researchers took patients' white blood cells, genetically engineered them to recognize a protein called E7 found in HPV cancer cells, and infused them back. Patients also rec…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Blood test may catch pelvic cancer relapse sooner
Diagnosis CompletedThis study looks at whether a blood test that detects tumor DNA can find early signs of cancer returning in people treated for HPV-positive pelvic cancers (like cervical or anal cancer). Researchers will take blood samples from 172 patients during regular follow-up visits. The go…
Sponsor: Institut Curie • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Cancer Survivors' sex drive gets a boost: bupropion shows promise
Symptom relief CompletedThis study tested whether bupropion, a medication that affects brain chemicals, can improve low sexual desire in women who have had breast or gynecologic cancer. About 230 women took either bupropion or a placebo pill for 9 weeks. The main goal was to see if their self-reported s…
Phase 2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Can pelvic PT help cancer survivors regain sexual health?
Symptom relief CompletedThis study looked at whether a 10-week pelvic physical therapy program is practical for gynecologic cancer survivors who have sexual problems. Twenty survivors were enrolled to see if they could stick with the program and if it improved their sexual function and quality of life. …
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Question list may empower gynecologic cancer patients in clinic
Knowledge-focused CompletedThis study tests whether giving gynecologic cancer patients a list of questions to ask their doctor improves their confidence, reduces distress, and builds trust. About 70 adults with newly diagnosed or suspected gynecologic cancer will either receive the question list or usual c…
Sponsor: Ira Winer • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Embarrassment may be costing lives: study probes why women delay cancer checks
Knowledge-focused CompletedThis study interviewed 12 women diagnosed with gynaecological cancers (ovarian, womb, cervical, vulval, or vaginal) to understand what made them seek help or delay. Researchers focused on embarrassment and other barriers to early doctor visits. The goal is to use these insights t…
Sponsor: NHS Grampian • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC